Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02073435 · ClinicalTrials.gov registry record
A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation
A clinical trial, sponsored by Northwestern University.
- Completed
- Registry status
- 177
- Enrollment target
NCT02073435: Completed study, sponsored by Northwestern University.
NCT02073435 is a clinical trial that has completed, run by Northwestern University. The registered enrollment target is 177 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02073435 has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- 177 participants
- Enrollment target
Study Summary
Living donor liver transplantation (LDLT), involves complex systems and processes of care that are particularly vulnerable to medical errors and preventable complications. This ancillary study of the Adult-to-Adult Living Liver Transplantation Cohort Study (A2ALL) will focus on conducting a proactive, systematic, and comprehensive assessment of the vulnerabilities in the systems and process of LDLT care to reduce medical errors and preventable complications thereby improving the safety of LDLT care. This project will address an important gap in the knowledge needed to achieve high quality and safe LDLT care of patients by developing a process to: 1) proactively, systematically and comprehensively identify areas of vulnerabilities in LDLT care that can result in medical errors, 2) design and implement solutions to mitigate these weaknesses, and 3) evaluate the effectiveness of these solutions to improve the safety of LDLT care by measuring clinical and process outcomes before and after solution implementation across four A2ALL participating transplant centers
Primary Outcome
Comparison of Average Pain Scores on Visual Analogue Pain Scale (0-10) measured before and after implementation of evidence-based donor pain management solution. 0 representing "No Pain", up through 10 representing "Worst possible, unbearable, excruciating pain".
Interventions
- BEHAVIORAL Donor pain management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2010-10 |
| Est. Completion | 2018-04 |
What the finished NCT02073435 record still lists
NCT02073435 is an observational study that tracks outcomes without assigning an intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Donor pain management is the first listed.
NCT02073435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02073435 about?
NCT02073435 is a clinical study titled "A2ALL-Patients Safety System Improvements in Living Donor Liver Transplantation". Living donor liver transplantation (LDLT), involves complex systems and processes of care that are particularly vulnerable to medical errors and preventable complications. This ancillary study of the Adult-to-Adult Living Liver Transplantation Cohort Study (A2ALL) will focus on conducting a proactiv...
What is the current status of trial NCT02073435?
This trial is currently completed. The enrollment target is 177 participants. The study started on 2010-10. Estimated completion is 2018-04.
What interventions are being tested in trial NCT02073435?
The interventions under investigation include: Donor pain management (BEHAVIORAL).
Who is sponsoring clinical trial NCT02073435?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia